Lung cancer trials in Estonia

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

  Where

  Tallinn, Tartu Linn

  Age

  18 years and over

  People

  670 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07472517 · EU 2025-520565-51-00
• Phase 3Taking people
  A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.

  Where

  Tallinn

  Age

  18 years and over

  People

  290 worldwide

  Run by

  ETOP IBCSG Partners Foundation

  See details and how to joinNCT06284317 · EU 2023-508773-82-00
• Phase 3Taking people
  A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy

  Where

  Tallinn

  Age

  18 years and over

  People

  390 worldwide

  Run by

  ETOP IBCSG Partners Foundation

  See details and how to joinNCT06931717 · EU 2024-519901-36-00
• Phase 3Not yet taking people in Estonia
  Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?

  Where

  Tallinn

  Age

  18 years and over

  People

  426 worldwide

  Run by

  Norges Teknisk-Naturvitenskapelige Universitet NTNU

  See details and how to join2026-525513-31-00 · EU 2026-525513-31-00